Summary

The cell dissociation market is projected to grow from USD 0.6 billion in 2023 to USD 1.4 billion by 2028 at a CAGR of 17.8%. The key factors driving the growth of the cell dissociation market are the increase in recombinant therapeutics sourced from mammalian cells, the growing focus on personalized medicine, and increasing GMP certification approvals for cell therapy production facilities. Additionally, advancements in non-enzymatic tissue dissociation are expected to offer lucrative market opportunities.

“Enzymatic dissociation products segment to witness the highest growth during the forecast period.”
Based on product, the cell dissociation market is segmented into enzymatic dissociation agents, non-enzymatic dissociation agents, and instruments & accessories. The enzymatic dissociation agents segment dominated the cell dissociation market in 2022. It is expected to hold the largest share till 2028. The expanding pool of operational entities in this segment and established protocols for using enzymatic dissociation agents are key contributors to market growth.
Non-enzymatic alternatives for cell dissociation are being developed to overcome the limitations of traditional enzymes. Instruments and accessories form a niche segment, with few manufacturers active.
“Connective tissue segment to register the highest growth in the cell dissociation market during the forecast period.”
Based on tissue type, the cell dissociation market has been segmented into connective tissue, epithelial tissue, and other tissues (muscle tissue, lung tissue, and nerve tissue). Connective tissue dominated the cell dissociation market in 2022. The extensive research on connective tissues has ensured a high share of this segment. However, the epithelial tissue segment is expected to grow at the highest rate over the forecast period.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
The cell dissociation market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The Asia Pacific market is estimated to register the highest growth during the forecast period primarily due to the rising R&D investments in the pharmaceutical sectors of several emerging APAC countries, favorable regulatory guidelines & government support, lower manufacturing costs, and increasing incidence of diseases.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Respondent: Supply Side (20%) , Demand side (80%)
• By Designation: C-level (20%), Director-level (25%), and Others (55%)
• By Region: North America (40%), Europe (28%), AsiaPacific (20%), and Rest of the World(12%)


List of Companies Profiled in the Report
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Thermo Fisher Scientific, Inc. (US)
• Corning Incorporated (US)
• Becton, Dickinson and Company (US)
• STEMCELL Technologies (Canada)
• PromoCell GmbH (Germany)
• Miltenyi Biotec (Germany)
• ATCC (US)
• HiMedia Laboratories (India)
• PAN-Biotech (Germany)
• CellSystems GmbH (Germany)
• AMSBIO (England)
• Neuromics (US)
• VitaCyte, LLC. (US)
• ALSTEM (US)
• Biological Industries (Israel)
• Gemini Bio (US)
• Innovative Cell Technologies, Inc. (US)
• Central Drug House (P) Ltd. (India)
• Worthington Biochemical Corporation (US)
• Capricorn Scientific (Germany)
• Abeomics (US)
• Genlantis, Inc. (US)

Research Coverage
This report studies the cell dissociation market based on product, tissue type, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell dissociation market. The report forecasts the revenue of the market segments with respect to four major regions.


Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on cell dissociation products offered by the top 25 players in the cell dissociation market. The report analyzes the cell dissociation market by product, tissue type, application, end user, and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.


• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the cell dissociation market

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell dissociation market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS AND EXCLUSIONS 31
1.3 STUDY SCOPE 32
1.4 YEARS CONSIDERED 32
1.5 CURRENCY CONSIDERED 33
1.6 LIMITATIONS 33
1.7 STAKEHOLDERS 33
1.8 RECESSION IMPACT 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH APPROACH 34
FIGURE 1 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 34
2.1.2 PRIMARY DATA 35
FIGURE 2 BREAKDOWN OF PRIMARIES: CELL DISSOCIATION MARKET 36
2.2 MARKET SIZE ESTIMATION 37
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF CELL DISSOCIATION COMPANIES 37
FIGURE 4 AVERAGE MARKET SIZE ESTIMATION, 2022 38
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 39
FIGURE 5 CELL DISSOCIATION MARKET: CAGR PROJECTIONS, 2022–2027 39
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 40
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 41
FIGURE 7 DATA TRIANGULATION METHODOLOGY 41
2.5 INSIGHTS FROM PRIMARIES 42
FIGURE 8 MARKET VALIDATION FROM PRIMARY EXPERTS 42
2.6 RESEARCH ASSUMPTIONS 42
2.7 RISK ASSESSMENT 43
2.8 RECESSION IMPACT ANALYSIS 43
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 43
3 EXECUTIVE SUMMARY 45
FIGURE 9 CELL DISSOCIATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 45
FIGURE 10 CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2023 VS. 2028 (USD MILLION) 46
FIGURE 11 CELL DISSOCIATION MARKET, BY APPLICATION, 2022 VS. 2026 (USD MILLION) 46
FIGURE 12 CELL DISSOCIATION MARKET, BY END USER, 2022 VS. 2026 (USD MILLION) 47
FIGURE 13 GEOGRAPHICAL SNAPSHOT 47
4 PREMIUM INSIGHTS 49
4.1 CELL DISSOCIATION MARKET OVERVIEW 49
FIGURE 14 INCREASING INVESTMENTS AND FUNDING FOR CELL RESEARCH TO DRIVE MARKET 49
4.2 NORTH AMERICA: CELL DISSOCIATION MARKET 50
FIGURE 15 ENZYMATIC DISSOCIATION AGENTS TO COMMAND LARGEST SHARE OF NORTH AMERICAN MARKET 50
4.3 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2023 VS. 2028 (USD MILLION) 50
FIGURE 16 EPITHELIAL TISSUE SEGMENT TO GROW AT HIGHEST CAGR IN NORTH AMERICA 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
FIGURE 17 CELL DISSOCIATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
TABLE 2 CELL DISSOCIATION MARKET: IMPACT ANALYSIS 52
5.2.1 DRIVERS 52
5.2.1.1 Increase in recombinant therapeutics sourced from mammalian cells 52
FIGURE 18 RISE IN MARKETED THERAPEUTICS, 2002 VS 2022 53
FIGURE 19 MARKETED THERAPEUTICS, BY ORIGIN, 2022 53
5.2.1.2 Growing focus on personalized medicine 54
FIGURE 20 SHARE OF PERSONALIZED MEDICINES IN TOTAL NUMBER OF FDA-APPROVED NEW MOLECULAR ENTITIES, 2015–2021 54
5.2.1.3 cGMP approvals for new cell therapy production facilities 54
TABLE 3 NEW GMP FACILITIES AND EXPANSIONS, 2017-2022 55
5.2.2 RESTRAINTS 55
5.2.2.1 High cost of cell-based research 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Advancements in non-enzymatic tissue dissociation 55
5.2.4 CHALLENGES 56
5.2.4.1 Limitations associated with dissociated cell culture 56
5.3 TECHNOLOGY ANALYSIS 56
5.4 SUPPLY/VALUE CHAIN ANALYSIS 57
FIGURE 21 CELL DISSOCIATION MARKET: VALUE CHAIN ANALYSIS 58
5.5 ECOSYSTEM ANALYSIS 58
FIGURE 22 CELL DISSOCIATION MARKET: ECOSYSTEM ANALYSIS 58
5.6 PORTER’S FIVE FORCES ANALYSIS 59
TABLE 4 CELL DISSOCIATION MARKET: PORTER’S FIVE FORCES ANALYSIS 59
5.6.1 THREAT OF NEW ENTRANTS 59
5.6.2 THREAT OF SUBSTITUTES 59
5.6.3 BARGAINING POWER OF SUPPLIERS 59
5.6.4 BARGAINING POWER OF BUYERS 59
5.6.5 DEGREE OF COMPETITION 60
5.7 REGULATORY ANALYSIS 60
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 8 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
5.8 PRICING ANALYSIS 62
TABLE 9 AVERAGE SELLING PRICES OF KEY PLAYERS, BY PRODUCT (REAGENTS) 62
5.8.1 AVERAGE SELLING PRICE TREND 63
TABLE 10 PRICING TRENDS FOR CELL DISSOCIATION REAGENTS OFFERED BY KEY PLAYERS 63
5.9 KEY CONFERENCES & EVENTS, 2023–2024 63
TABLE 11 CELL DISSOCIATION CONFERENCES & EVENTS (2023–2024) 63
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 64
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 64
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL DISSOCIATION PRODUCTS 64
5.10.2 BUYING CRITERIA FOR CELL DISSOCIATION PRODUCTS 65
FIGURE 24 KEY BUYING CRITERIA FOR END USERS 65
6 CELL DISSOCIATION MARKET, BY PRODUCT 66
6.1 INTRODUCTION 67
TABLE 12 CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 67
6.2 ENZYMATIC DISSOCIATION AGENTS 67
TABLE 13 CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION AGENTS, BY TYPE, 2021–2028 (USD MILLION) 68
TABLE 14 CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION AGENTS, BY REGION, 2021–2028 (USD MILLION) 68
TABLE 15 NORTH AMERICA: CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 68
TABLE 16 EUROPE: CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 69
TABLE 17 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 69
6.2.1 COLLAGENASE 70
6.2.1.1 Collagenase to hold largest share of enzymatic dissociation agents market 70
TABLE 18 CELL DISSOCIATION MARKET FOR COLLAGENASE, BY REGION, 2021–2028 (USD MILLION) 70
TABLE 19 NORTH AMERICA: CELL DISSOCIATION MARKET FOR COLLAGENASE, BY COUNTRY, 2021–2028 (USD MILLION) 70
TABLE 20 EUROPE: CELL DISSOCIATION MARKET FOR COLLAGENASE, BY COUNTRY, 2021–2028 (USD MILLION) 71
TABLE 21 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR COLLAGENASE, BY COUNTRY, 2021–2028 (USD MILLION) 71
6.2.2 TRYPSIN 71
6.2.2.1 Established protocols for using trypsin to contribute to segment growth 71
TABLE 22 CELL DISSOCIATION MARKET FOR TRYPSIN, BY REGION, 2021–2028 (USD MILLION) 72
TABLE 23 NORTH AMERICA: CELL DISSOCIATION MARKET FOR TRYPSIN, BY COUNTRY, 2021–2028 (USD MILLION) 72
TABLE 24 EUROPE: CELL DISSOCIATION MARKET FOR TRYPSIN, BY COUNTRY, 2021–2028 (USD MILLION) 72
TABLE 25 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR TRYPSIN, BY COUNTRY, 2021–2028 (USD MILLION) 73
6.2.3 PAPAIN 73
6.2.3.1 Benefits of papain-based dissociation to drive usage 73
TABLE 26 CELL DISSOCIATION MARKET FOR PAPAIN, BY REGION, 2021–2028 (USD MILLION) 73
TABLE 27 NORTH AMERICA: CELL DISSOCIATION MARKET FOR PAPAIN, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 28 EUROPE: CELL DISSOCIATION MARKET FOR PAPAIN, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 29 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR PAPAIN, BY COUNTRY, 2021–2028 (USD MILLION) 74
6.2.4 ELASTASE 75
6.2.4.1 Elastase to find frequent use in dissociating tissues containing extensive intercellular fiber networks 75
TABLE 30 CELL DISSOCIATION MARKET FOR ELASTASE, BY REGION, 2021–2028 (USD MILLION) 75
TABLE 31 NORTH AMERICA: CELL DISSOCIATION MARKET FOR ELASTASE, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 32 EUROPE: CELL DISSOCIATION MARKET FOR ELASTASE, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 33 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR ELASTASE, BY COUNTRY, 2021–2028 (USD MILLION) 76
6.2.5 DNASE 76
6.2.5.1 Increasing demand in single-cell suspensions to propel market 76
TABLE 34 CELL DISSOCIATION MARKET FOR DNASE, BY REGION, 2021–2028 (USD MILLION) 77
TABLE 35 NORTH AMERICA: CELL DISSOCIATION MARKET FOR DNASE, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 36 EUROPE: CELL DISSOCIATION MARKET FOR DNASE, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 37 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR DNASE, BY COUNTRY, 2021–2028 (USD MILLION) 78
6.2.6 HYALURONIDASE 78
6.2.6.1 Increasing use of hyaluronidase as supplement for tissue dissociation to support market growth 78
TABLE 38 CELL DISSOCIATION MARKET FOR HYALURONIDASE, BY REGION, 2021–2028 (USD MILLION) 78
TABLE 39 NORTH AMERICA: CELL DISSOCIATION MARKET FOR HYALURONIDASE, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 40 EUROPE: CELL DISSOCIATION MARKET FOR HYALURONIDASE, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 41 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR HYALURONIDASE, BY COUNTRY, 2021–2028 (USD MILLION) 79
6.2.7 OTHER ENZYMES 80
TABLE 42 CELL DISSOCIATION MARKET FOR OTHER ENZYMES, BY REGION, 2021–2028 (USD MILLION) 80
TABLE 43 NORTH AMERICA: CELL DISSOCIATION MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 44 EUROPE: CELL DISSOCIATION MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 45 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR OTHER ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION) 81
6.3 NON-ENZYMATIC DISSOCIATION AGENTS 82
6.3.1 HIGH YIELD AND OTHER BENEFITS TO DRIVE DEMAND FOR NON-ENZYMATIC PRODUCTS 82
TABLE 46 CELL DISSOCIATION MARKET FOR NON-ENZYMATIC DISSOCIATION AGENTS, BY REGION, 2021–2028 (USD MILLION) 82
TABLE 47 NORTH AMERICA: CELL DISSOCIATION MARKET FOR NON-ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 48 EUROPE: CELL DISSOCIATION MARKET FOR NON-ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 49 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR NON-ENZYMATIC DISSOCIATION AGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 83
6.4 INSTRUMENTS & ACCESSORIES 83
6.4.1 INTRODUCTION OF ADVANCED BENCHTOP INSTRUMENTS TO PROPEL MARKET 83
TABLE 50 CELL DISSOCIATION MARKET FOR INSTRUMENTS & ACCESSORIES, BY REGION, 2021–2028 (USD MILLION) 84
TABLE 51 NORTH AMERICA: CELL DISSOCIATION MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 52 EUROPE: CELL DISSOCIATION MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 53 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 85
 
7 CELL DISSOCIATION MARKET, BY TISSUE TYPE 86
7.1 INTRODUCTION 87
TABLE 54 CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 87
7.2 CONNECTIVE TISSUE 87
7.2.1 EXTENSIVE RESEARCH ON CONNECTIVE TISSUES TO PROPEL SEGMENT GROWTH 87
FIGURE 25 NUMBER OF RESEARCH ARTICLES FOR CONNECTIVE TISSUE, 2020–2022 88
TABLE 55 CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 56 NORTH AMERICA: CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 57 EUROPE: CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 58 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY COUNTRY, 2021–2028 (USD MILLION) 89
7.3 EPITHELIAL TISSUE 90
7.3.1 NEW PROTOCOLS TO COMBAT DISSOCIATION-INDUCED CHANGES IN EPITHELIAL CELLS LIKELY TO SUPPORT GROWTH 90
TABLE 59 CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 60 NORTH AMERICA: CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 61 EUROPE: CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 62 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY COUNTRY, 2021–2028 (USD MILLION) 91
7.4 OTHER TISSUES 92
TABLE 63 CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY REGION, 2021–2028 (USD MILLION) 92
TABLE 64 NORTH AMERICA: CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 65 EUROPE: CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 66 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY COUNTRY, 2021–2028 (USD MILLION) 93
8 CELL DISSOCIATION MARKET, BY APPLICATION 94
8.1 INTRODUCTION 95
TABLE 67 CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 95
8.2 TISSUE DISSOCIATION 95
8.2.1 INCREASING USE OF TISSUE DISSOCIATION PRODUCTS IN SINGLE-CELL ANALYSIS TO CONTRIBUTE TO SEGMENT GROWTH 95
TABLE 68 TISSUE DISSOCIATION MARKET, BY REGION, 2021–2028 (USD MILLION) 95
TABLE 69 NORTH AMERICA: TISSUE DISSOCIATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 70 EUROPE: TISSUE DISSOCIATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 71 ASIA PACIFIC: TISSUE DISSOCIATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
8.3 CELL DETACHMENT 97
8.3.1 USE OF CELL DETACHMENT PRODUCTS IN ADHERENT CELL CULTURES TO DRIVE MARKET 97
TABLE 72 CELL DETACHMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 73 NORTH AMERICA: CELL DETACHMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 74 EUROPE: CELL DETACHMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 75 ASIA PACIFIC: CELL DETACHMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
9 CELL DISSOCIATION MARKET, BY END USER 99
9.1 INTRODUCTION 100
TABLE 76 CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 100
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 100
9.2.1 PHARMA & BIOTECH COMPANIES TO HOLD LARGEST MARKET SHARE 100
TABLE 77 CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 78 NORTH AMERICA: CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 79 EUROPE: CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 80 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 102
9.3 RESEARCH & ACADEMIC INSTITUTES 102
9.3.1 RISING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET 102
TABLE 81 CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 82 NORTH AMERICA: CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 83 EUROPE: CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 84 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 104
9.4 OTHER END USERS 104
TABLE 85 CELL DISSOCIATION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 86 NORTH AMERICA: CELL DISSOCIATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 87 EUROPE: CELL DISSOCIATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 88 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 106
 
10 CELL DISSOCIATION MARKET, BY REGION 107
10.1 INTRODUCTION 108
TABLE 89 CELL DISSOCIATION MARKET, BY REGION, 2021–2028 (USD MILLION) 108
10.2 NORTH AMERICA 109
10.2.1 RECESSION IMPACT 109
FIGURE 26 NORTH AMERICA: CELL DISSOCIATION MARKET SNAPSHOT 110
TABLE 90 NORTH AMERICA: CELL DISSOCIATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 91 NORTH AMERICA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 111
TABLE 92 NORTH AMERICA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 93 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 111
TABLE 94 NORTH AMERICA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 112
TABLE 95 NORTH AMERICA: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 112
10.2.2 US 112
10.2.2.1 US to dominate North American market 112
TABLE 96 US: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 113
TABLE 97 US: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
TABLE 98 US: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 114
TABLE 99 US: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 114
TABLE 100 US: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 114
10.2.3 CANADA 115
10.2.3.1 Advancements in regenerative medicine to drive market 115
TABLE 101 CANADA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 115
TABLE 102 CANADA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 103 CANADA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 116
TABLE 104 CANADA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
TABLE 105 CANADA: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 117
10.3 EUROPE 117
10.3.1 RECESSION IMPACT 117
TABLE 106 EUROPE: CELL DISSOCIATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 107 EUROPE: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 118
TABLE 108 EUROPE: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 109 EUROPE: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 119
TABLE 110 EUROPE: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
TABLE 111 EUROPE: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 119
10.3.2 GERMANY 120
10.3.2.1 Germany to hold largest share of European market 120
TABLE 112 GERMANY: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 120
TABLE 113 GERMANY: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 114 GERMANY: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 121
TABLE 115 GERMANY: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 121
TABLE 116 GERMANY: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 122
10.3.3 UK 122
10.3.3.1 Government investments in biotech industry to support market growth 122
TABLE 117 UK: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 122
TABLE 118 UK: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 119 UK: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 123
TABLE 120 UK: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 123
TABLE 121 UK: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 124
10.3.4 FRANCE 124
10.3.4.1 Increasing R&D investments by key players to boost market 124
TABLE 122 FRANCE: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 124
TABLE 123 FRANCE: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 124 FRANCE: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 125
TABLE 125 FRANCE: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 125
TABLE 126 FRANCE: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 126
10.3.5 ITALY 126
10.3.5.1 Large life science research base in Italy to boost market prospects 126
TABLE 127 ITALY: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 126
TABLE 128 ITALY: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 129 ITALY: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 127
TABLE 130 ITALY: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 127
TABLE 131 ITALY: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 128
10.3.6 SPAIN 128
10.3.6.1 Increasing funding from private and public organizations to aid market growth 128
TABLE 132 SPAIN: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 128
TABLE 133 SPAIN: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 134 SPAIN: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 129
TABLE 135 SPAIN: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 136 SPAIN: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 130
10.3.7 REST OF EUROPE 130
TABLE 137 ROE: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 138 ROE: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 139 ROE: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 131
TABLE 140 ROE: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 141 ROE: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 132
10.4 ASIA PACIFIC 132
10.4.1 RECESSION IMPACT 132
FIGURE 27 ASIA PACIFIC: CELL DISSOCIATION MARKET SNAPSHOT 133
TABLE 142 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 143 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 134
TABLE 144 ASIA PACIFIC: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 145 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 135
TABLE 146 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 135
TABLE 147 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 135
 
10.4.2 CHINA 136
10.4.2.1 China to dominate APAC market 136
TABLE 148 CHINA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 149 CHINA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 150 CHINA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 137
TABLE 151 CHINA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 152 CHINA: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 138
10.4.3 JAPAN 138
10.4.3.1 Strategic developments by companies to drive market 138
TABLE 153 JAPAN: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 138
TABLE 154 JAPAN: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 155 JAPAN: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 139
TABLE 156 JAPAN: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 157 JAPAN: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 140
10.4.4 INDIA 140
10.4.4.1 Growing life sciences industry to push growth 140
TABLE 158 INDIA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 141
TABLE 159 INDIA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 160 INDIA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 141
TABLE 161 INDIA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 162 INDIA: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 142
10.4.5 AUSTRALIA 142
10.4.5.1 New cell/tissue culture technologies to promote market growth 142
TABLE 163 AUSTRALIA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 142
TABLE 164 AUSTRALIA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 165 AUSTRALIA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 143
TABLE 166 AUSTRALIA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143
TABLE 167 AUSTRALIA: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 144
10.4.6 SOUTH KOREA 144
10.4.6.1 Increasing pharmaceutical and biotech R&D investment to bolster market 144
TABLE 168 SOUTH KOREA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 145
TABLE 169 SOUTH KOREA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 170 SOUTH KOREA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 145
TABLE 171 SOUTH KOREA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 146
TABLE 172 SOUTH KOREA: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 146
10.4.7 REST OF ASIA PACIFIC 146
TABLE 173 ROAPAC: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 147
TABLE 174 ROAPAC: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 175 ROAPAC: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 147
TABLE 176 ROAPAC: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 177 ROAPAC: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 148
10.5 LATIN AMERICA 148
10.5.1 GOVERNMENT INVESTMENTS AND FAVORABLE FUNDING SCENARIO TO PROPEL MARKET 148
10.5.2 RECESSION IMPACT 149
TABLE 178 LATIN AMERICA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 149
TABLE 179 LATIN AMERICA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 180 LATIN AMERICA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 150
TABLE 181 LATIN AMERICA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 182 LATIN AMERICA: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 150
10.6 MIDDLE EAST & AFRICA 151
10.6.1 INCREASING R&D FUNDING FOR STEM CELL THERAPY TO BOOST MARKET 151
10.6.2 RECESSION IMPACT 151
TABLE 183 MIDDLE EAST & AFRICA: CELL DISSOCIATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 152
TABLE 184 MIDDLE EAST & AFRICA: ENZYMATIC DISSOCIATION AGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 185 MIDDLE EAST & AFRICA: CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2021–2028 (USD MILLION) 152
TABLE 186 MIDDLE EAST & AFRICA: CELL DISSOCIATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153
TABLE 187 MIDDLE EAST & AFRICA: CELL DISSOCIATION MARKET, BY END USER, 2021–2028 (USD MILLION) 153
11 COMPETITIVE LANDSCAPE 154
11.1 INTRODUCTION 154
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 155
FIGURE 28 CELL DISSOCIATION MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 155
11.3 MARKET SHARE ANALYSIS 156
FIGURE 29 CELL DISSOCIATION MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) 156
TABLE 188 CELL DISSOCIATION MARKET: DEGREE OF COMPETITION 156
11.4 REVENUE ANALYSIS 157
FIGURE 30 REVENUE ANALYSIS OF TOP FIVE MARKET PLAYERS (2020–2022) 157
11.5 COMPANY EVALUATION QUADRANT (2022) 158
11.5.1 STARS 158
11.5.2 EMERGING LEADERS 158
11.5.3 PERVASIVE PLAYERS 158
11.5.4 PARTICIPANTS 158
FIGURE 31 CELL DISSOCIATION MARKET: COMPANY EVALUATION MATRIX, 2022 159
11.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2022) 160
11.6.1 PROGRESSIVE COMPANIES 160
11.6.2 STARTING BLOCKS 160
11.6.3 RESPONSIVE COMPANIES 160
11.6.4 DYNAMIC COMPANIES 160
FIGURE 32 CELL DISSOCIATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 161
11.7 COMPETITIVE BENCHMARKING OF START-UPS/SMES 162
TABLE 189 CELL DISSOCIATION MARKET: DETAILED LIST OF KEY START-UPS/SMES 162
TABLE 190 CELL DISSOCIATION MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 163
11.8 COMPETITIVE SCENARIO AND TRENDS 163
11.8.1 PRODUCT LAUNCHES 163
TABLE 191 CELL DISSOCIATION MARKET: PRODUCT LAUNCHES, JANUARY 2020 TO JANUARY 2023 163
11.8.2 DEALS 164
TABLE 192 CELL DISSOCIATION MARKET: DEALS, JANUARY 2020 TO JANUARY 2023 164
 
12 COMPANY PROFILES 165
12.1 KEY PLAYERS 165
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 THERMO FISHER SCIENTIFIC 165
TABLE 193 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 165
FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021) 166
12.1.2 MERCK KGAA 169
TABLE 194 MERCK KGAA: BUSINESS OVERVIEW 169
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2021) 170
12.1.3 CYTIVA (DANAHER CORPORATION) 172
TABLE 195 CYTIVA: BUSINESS OVERVIEW 172
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 173
12.1.4 BECTON, DICKINSON AND COMPANY 175
TABLE 196 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 175
FIGURE 36 BD: COMPANY SNAPSHOT (2021) 176
12.1.5 CORNING INC. 177
TABLE 197 CORNING INC.: BUSINESS OVERVIEW 177
FIGURE 37 CORNING INC.: COMPANY SNAPSHOT (2020) 178
12.1.6 STEMCELL TECHNOLOGIES 179
TABLE 198 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW 179
12.1.7 PROMOCELL GMBH 181
TABLE 199 PROMOCELL GMBH: BUSINESS OVERVIEW 181
12.1.8 MILTENYI BIOTEC 182
TABLE 200 MILTENYI BIOTEC: BUSINESS OVERVIEW 182
12.1.9 ATCC 184
TABLE 201 ATCC: BUSINESS OVERVIEW 184
12.1.10 HIMEDIA LABORATORIES 186
TABLE 202 HIMEDIA LABORATORIES: BUSINESS OVERVIEW 186
12.1.11 PAN-BIOTECH 187
TABLE 203 PAN-BIOTECH: BUSINESS OVERVIEW 187
12.1.12 CELLSYSTEMS GMBH 188
TABLE 204 CELLSYSTEMS: BUSINESS OVERVIEW 188
12.1.13 AMSBIO 190
TABLE 205 AMSBIO: BUSINESS OVERVIEW 190
12.1.14 NEUROMICS 192
TABLE 206 NEUROMICS: BUSINESS OVERVIEW 192
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 193
12.2.1 VITACYTE 193
12.2.2 ALSTEMBIO 193
12.2.3 BIOLOGICAL INDUSTRIES (SARTORIUS) 194
12.2.4 GEMINIBIO 194
12.2.5 INNOVATIVE CELL TECHNOLOGIES, INC. 195
12.2.6 CENTRAL DRUG HOUSE (P) LTD. 195
12.2.7 WORTHINGTON BIOCHEMICAL CORPORATION 196
12.2.8 CAPRICORN SCIENTIFIC 196
12.2.9 ABEOMICS 197
12.2.10 GENLANTIS 197
13 APPENDIX 198
13.1 DISCUSSION GUIDE 198
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 201
13.3 CUSTOMIZATION OPTIONS 203
13.4 RELATED REPORTS 203
13.5 AUTHOR DETAILS 204